LIRALTAGENE AUTOLEUCEL EXPRESSED FOLLICLE STIMULATING HORMONE FUSION PROTEIN
UNII PR73HQV9RS

Substance Identification & Data

This profile provides standardized clinical and technical data for Liraltagene Autoleucel Expressed Follicle Stimulating Hormone Fusion Protein, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PR73HQV9RS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
PR73HQV9RS
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LIRALTAGENE AUTOLEUCEL EXPRESSED FOLLICLE STIMULATING HORMONE FUSION PROTEIN
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Liraltagene Autoleucel Expressed Follicle Stimulating Hormone Fusion Protein. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LIRALTAGENE AUTOLEUCEL EXPRESSED FOLLICLE STIMULATING HORMONE (FSH) (SUBUNITS FSH.BETA. AND CG.ALPHA.) FUSED TO A CD8.ALPHA. HINGE AND TRANSMEMBRANE DOMAIN, A 4-1BB CO-STIMULATORY DOMAIN AND A CD3.ZETA. SIGNALLING DOMAIN
LIRALTAGENE AUTOLEUCEL EXPRESSED FOLLICLE STIMULATING HORMONE FUSION PROTEIN

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record